Pembrolizumab for Newly Diagnosed Glioblastoma
Pembrolizumab for Newly Diagnosed Glioblastoma
Active, not recruiting · NCT03899857 · Registry updated 2024-05-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab for Newly Diagnosed Glioblastoma | Newly Diagnosed Glioblastoma | Active, not recruiting | Phase 2 | 2024-05-08 | NCT03899857 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
| University of Zurich | 188 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital Bern / Inselspital | Bern | Switzerland | 1 |
| University Hospital Lausanne, CHUV | Lausanne | Switzerland | 1 |
| University Hospital Zurich | Zurich | Switzerland | 42 |